Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. Du Bois, Elizabeth A. Fagan, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Kenneth F. Glasscock, Talmadge E. King, Lisa Lancaster, David J. Lederer, Zhengning Lin, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble, Athol U. Wells

Research output: Contribution to journalArticle

95 Scopus citations

Fingerprint Dive into the research topics of 'Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences